単純ヘルペスウイルス治療市場規模、シェア、動向分析レポート：タイプ別、薬剤別、ワクチン別、投与経路別、最終用途別、地域別、セグメント別予測、2024年～2030年

単純ヘルペスウイルス治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の単純ヘルペスウイルス治療市場規模は2030年までに40億8,000万米ドルに達し、2024年から2030年までのCAGRは8.1%で拡大すると予測されています。

市場開拓の背景には、人口におけるヘルペス感染症の有病率の増加、世界のこの病気に対する意識の高まり、高齢者や免疫不全人口の増加、ヘルペス感染症治療薬の需要を満たすための新規治療オプションの開発需要の高まりなどの要因があります。さらに、官民一体となった取り組みが市場の成長をさらに促進すると期待されています。

WHOによると、2020年には約4億9,150万人が単純ヘルペスウイルス2に起因する性器ヘルペスに罹患しており、数十億人が単純ヘルペスウイルス1に感染しています。この感染症は通常、無症状であるが、感染者は接触によって容易に他の人にウイルスを感染させることができます。さらに、世界人口の80％近くがヘルペスのキャリアです。このことは、ヘルペス感染症治療薬の成長機会を生み出しています。

研究イニシアティブと研究機関間の共同開発の増加は、ウイルスに対する新しい治療法の開発を促進し、市場成長を後押しすると予想されています。2020年1月、スイスのローザンヌにあるEPFL、ジュネーブ大学（UNIGE）、マンチェスター大学の科学者の共同研究により、単純ヘルペス（口唇ヘルペスウイルス）の治療に有望な、糖から作られた新規抗ウイルス物質であるビルシドが開発されました。砂糖から作られたビルシドの開発により、人体に毒性を持たずに治療を助ける革新的な抗ウイルス薬の登場が促進されました。

この市場で事業を展開する主な企業は、効果的な治療薬を提供する需要の増加に対応するため、新規かつ革新的な製品の開発に注力しています。効果的な治療薬に対する需要の増加に伴い、企業は感染症に対する新規かつ革新的な医薬品の開発に取り組んでいます。例えば、2021年7月、ドイツの製薬会社であるAiCuris Anti-infective Cures AGによる新薬プリテリビルのフェーズIII試験が開始されました。この代表的な化合物は、アシクロビル耐性を有する免疫不全の皮膚粘膜HSV感染症患者を治療するために開発されました。2020年6月に米国FDAより画期的治療薬指定を受けた。革新的な治療法に対する規制上の支援により、市場に参入する新薬の数が増加し、治療率の向上が促進され、それによって市場の成長が加速すると予測されます。

単純ヘルペスウイルス治療市場レポートハイライト

• 治療薬別では、感染有病率の高さからHSV-1分野が2023年に最大のシェアを占める。
• 薬剤別では、アシクロビルの有効性と経口剤および外用剤としての入手可能性により、アシクロビルセグメントが予測期間中に最も速い速度で成長すると予想されます。
• ワクチン別では、ワクチン候補として有望な結果を示している唯一のワクチンであるsimplirix分野が予測期間中に最も速い速度で成長すると予想されます。
• 性病に関する意識の高まりとヘルスケア支出の増加により、2023年の世界市場は北米が支配的でした。

目次

第1章 単純ヘルペスウイルス治療市場：調査手法と範囲

第2章 単純ヘルペスウイルス治療市場：エグゼクティブサマリー

• 市場概要

第3章 単純ヘルペスウイルス治療市場：業界の展望

• 市場系統の見通し
• 普及と成長の見通しマッピング
• 市場力学
• ポーターのファイブフォース分析
• SWOT分析、要因別（政治・法律、経済、技術）
• 規制の枠組み
• ユーザー視点の分析

第4章 単純ヘルペスウイルス治療市場：競合情勢

• 主要市場参入企業による最近の動向と影響分析
• Major deals &strategic alliances analysis
• 会社/競合の分類
• ベンダー情勢
• 公開会社
• 非公開会社

第5章 単純ヘルペスウイルス治療市場：タイプビジネス分析

• 定義と範囲
• タイプ市場シェア分析、2023年および2030年
• 世界の単純ヘルペスウイルス治療市場、タイプ別、2018年から2030年
• 2018年から2030年の市場規模、予測、動向分析

第6章 単純ヘルペスウイルス治療市場：医薬品ビジネス分析

• 定義と範囲
• 医薬品市場シェア分析、2023年および2030年
• 世界の単純ヘルペスウイルス治療市場、薬剤別、2018年から2030年
• 2018年から2030年の市場規模、予測、動向分析

第7章 単純ヘルペスウイルス治療市場：ワクチンビジネス分析

• 定義と範囲
• ワクチン市場シェア分析、2023年および2030年
• 世界の単純ヘルペスウイルス治療市場、ワクチン別、2018年から2030年
• 2018年から2030年の市場規模、予測、動向分析

第8章 単純ヘルペスウイルス治療市場：投与経路ビジネス分析

• 定義と範囲
• 投与経路の市場シェア分析、2023年および2030年
• 世界の単純ヘルペスウイルス治療市場、投与経路別、2018年から2030年
• 2018年から2030年の市場規模、予測、動向分析

第9章 単純ヘルペスウイルス治療市場：最終用途ビジネス分析

• 定義と範囲
• 最終用途市場シェア分析、2023年および2030年
• 世界の単純ヘルペスウイルス治療市場、最終用途別、2018年から2030年
• 2018年から2030年の市場規模、予測、動向分析

第10章 単純ヘルペスウイルス治療市場：地域ビジネス分析

• 定義と範囲
• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析、要因別（政治・法律、経済・技術）
• 市場規模、予測、動向分析、2023年から2030年まで
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第11章 単純ヘルペスウイルス治療市場：企業プロファイル

• 企業プロファイル
• GSK plc
• Carlsbad Tech
• Emcure Pharmaceuticals Ltd.,
• Sanofi
• Glenmark Pharmaceuticals Inc.
• Fresenius Kabi AG
• Apotex Inc.
• Viatris Inc. (Mylan)
• Teva Pharmaceuticals Industries Ltd.

List of Tables

• TABLE 1 List of Secondary Sources
• TABLE 2 List of Abbreviations
• TABLE 3 Regulatory Framework
• TABLE 4 Global Herpes Simplex Virus Treatment Market, By Region, 2018 - 2030 (USD Million)
• TABLE 5 Global Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 6 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 7 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 8 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 9 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 10 North America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
• TABLE 11 North America Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 12 North America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 13 North America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 14 North America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 15 North America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 16 U.S. Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 17 U.S. Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 18 U.S. Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 19 U.S. Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 20 U.S. Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 21 Canada Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 22 Canada Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 23 Canada Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 24 Canada Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 25 Canada Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 26 Europe Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
• TABLE 27 Europe Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 28 Europe Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 29 Europe Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 30 Europe Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 31 Europe Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 32 UK Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 33 UK Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 34 UK Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 35 UK Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 36 UK Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 37 Germany Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 38 Germany Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 39 Germany Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 40 Germany Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 41 Germany Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 42 France Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 43 France Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 44 France Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 45 France Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 46 France Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 47 Spain Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 48 Spain Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 49 Spain Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 50 Spain Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 51 Spain Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 52 Italy Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 53 Italy Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 54 Italy Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 55 Italy Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 56 Italy Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 57 Denmark Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 58 Denmark Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 59 Denmark Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 60 Denmark Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 61 Denmark Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 62 Sweden Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 63 Sweden Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 64 Sweden Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 65 Sweden Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 66 Sweden Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 67 Norway Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 68 Norway Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 69 Norway Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 70 Norway Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 71 Norway Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 72 Asia Pacific Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
• TABLE 73 Asia Pacific Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 74 Asia Pacific Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 75 Asia Pacific Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 76 Asia Pacific Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 77 Asia Pacific Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 78 China Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 79 China Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 80 China Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 81 China Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 82 China Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 83 Japan Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 84 Japan Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 85 Japan Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 86 Japan Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 87 Japan Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 88 India Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 89 India Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 90 India Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 91 India Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 92 India Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 93 South Korea Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 94 South Korea Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 95 South Korea Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 96 South Korea Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 97 South Korea Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 98 Australia Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 99 Australia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 100 Australia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 101 Australia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 102 Australia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 103 Thailand Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 104 Thailand Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 105 Thailand Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 106 Thailand Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 107 Thailand Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 108 Latin America Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
• TABLE 109 Latin America Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 110 Latin America Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 111 Latin America Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 112 Latin America Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 113 Latin America Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 114 Brazil Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 115 Brazil Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 116 Brazil Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 117 Brazil Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 118 Brazil Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 119 Mexico Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 120 Mexico Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 121 Mexico Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 122 Mexico Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 123 Mexico Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 124 Argentina Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 125 Argentina Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 126 Argentina Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 127 Argentina Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 128 Argentina Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 129 MEA Herpes Simplex Virus Treatment Market, By Country, 2018 - 2030 (USD Million)
• TABLE 130 MEA Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 131 MEA Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 132 MEA Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 133 MEA Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 134 MEA Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 135 South Africa Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 136 South Africa Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 137 South Africa Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 138 South Africa Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 139 South Africa Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 140 Saudi Arabia Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 141 Saudi Arabia Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 142 Saudi Arabia Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 143 Saudi Arabia Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 144 Saudi Arabia Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 145 UAE Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 146 UAE Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 147 UAE Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 148 UAE Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 149 UAE Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)
• TABLE 150 Kuwait Herpes Simplex Virus Treatment Market, By Type, 2018 - 2030 (USD Million)
• TABLE 151 Kuwait Herpes Simplex Virus Treatment Market, By Drug, 2018 - 2030 (USD Million)
• TABLE 152 Kuwait Herpes Simplex Virus Treatment Market, By Vaccine, 2018 - 2030 (USD Million)
• TABLE 153 Kuwait Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
• TABLE 154 Kuwait Herpes Simplex Virus Treatment Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

• FIG. 1 Market Research Process
• FIG. 2 Information Procurement
• FIG. 3 Primary Research Pattern
• FIG. 4 Market Research Approaches
• FIG. 5 Value Chain-Based Sizing & Forecasting
• FIG. 6 Market Formulation & Validation
• FIG. 7 Herpes Simplex Virus Treatment Market Segmentation
• FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
• FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
• FIG. 11 Penetration & Growth Prospect Mapping
• FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• FIG. 13 Porter's Five Forces Analysis
• FIG. 14 Market Penetration & Growth Prospect Mapping
• FIG. 15 Herpes Simplex Virus Treatment Market: Treatment Movement Analysis
• FIG. 16 Herpes Simplex Virus-1 (HSV-1)market, 2018 - 2030 (USD Million)
• FIG. 17 Herpes simplex virus-2 (HSV-2)market, 2018 - 2030 (USD Million)
• FIG. 18 Herpes Simplex Virus Treatment Market: Drug Movement Analysis
• FIG. 19 Acyclovir market, 2018 - 2030 (USD Million)
• FIG. 20 Valacyclovir market, 2018 - 2030 (USD Million)
• FIG. 21 Famciclovir market, 2018 - 2030 (USD Million)
• FIG. 22 Others drugs market, 2018 - 2030 (USD Million)
• FIG. 23 Herpes Simplex Virus Treatment Market: Vaccine Movement Analysis
• FIG. 24 Herpes Simplex Virus Treatment Market: Route of Administration Movement Analysis
• FIG. 25 Oral market, 2018 - 2030 (USD Million)
• FIG. 26 Injectable market, 2018 - 2030 (USD Million)
• FIG. 27 Topical market, 2018 - 2030 (USD Million)
• FIG. 28 Herpes Simplex Virus Treatment Market: End-use Movement Analysis
• FIG. 29 Hospital pharmacy market, 2018 - 2030 (USD Million)
• FIG. 30 Retail pharmacy market, 2018 - 2030 (USD Million)
• FIG. 31 Online pharmacy market, 2018 - 2030 (USD Million)
• FIG. 32 Regional Marketplace: Key Takeaways
• FIG. 33 Regional Outlook, 2018 & 2030
• FIG. 34 Regional Market Dashboard
• FIG. 35 Regional Market Place: Key Takeaways
• FIG. 36 North America, SWOT Analysis
• FIG. 37 Europe, SWOT Analysis
• FIG. 38 Asia Pacific, SWOT Analysis
• FIG. 39 Latin America, SWOT Analysis
• FIG. 40 MEA, SWOT Analysis
• FIG. 41 North America
• FIG. 42 North America Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 43 U.S. Key Country Dynamics
• FIG. 44 U.S. Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 45 Canada Key Country Dynamics
• FIG. 46 Canada Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 47 Europe
• FIG. 48 Europe Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 49 UK Key Country Dynamics
• FIG. 50 UK Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 51 Germany Key Country Dynamics
• FIG. 52 Germany Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 53 France Key Country Dynamics
• FIG. 54 France Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 55 Italy Key Country Dynamics
• FIG. 56 Italy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 57 Spain Key Country Dynamics
• FIG. 58 Spain Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 59 Denmark Key Country Dynamics
• FIG. 60 Denmark Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 61 Sweden Key Country Dynamics
• FIG. 62 Sweden Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 63 Norway Key Country Dynamics
• FIG. 64 Norway Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 65 Asia Pacific
• FIG. 66 Asia-Pacific Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 67 Japan Key Country Dynamics
• FIG. 68 Japan Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 69 China Key Country Dynamics
• FIG. 70 China Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 71 India Key Country Dynamics
• FIG. 72 India Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 73 Australia Key Country Dynamics
• FIG. 74 Australia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 75 South Korea Key Country Dynamics
• FIG. 76 South Korea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 77 Thailand Key Country Dynamics
• FIG. 78 Thailand Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 79 Latin America
• FIG. 80 Latin America Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 81 Brazil Key Country Dynamics
• FIG. 82 Brazil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 83 Mexico Key Country Dynamics
• FIG. 84 Mexico Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 85 Argentina Key Country Dynamics
• FIG. 86 Argentina Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 87 MEA
• FIG. 88 MEA Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 89 South Africa Key Country Dynamics
• FIG. 90 South Africa Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 91 Saudi Arabia Key Country Dynamics
• FIG. 92 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 93 UAE Key Country Dynamics
• FIG. 94 UAE Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 95 Kuwait Key Country Dynamics
• FIG. 96 Kuwait Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• FIG. 97 Strategy Mapping

Herpes Simplex Virus Treatment Market Growth & Trends:

The global herpes simplex virus treatment market size is expected to reach USD 4.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2024 to 2030. The growth of the market is attributed to factors such as increasing prevalence of herpes infection among the population, growing awareness about the disease globally, rising geriatric and immunocompromised population, and an increasing demand to develop novel treatment options to meet the demand for herpes infection therapeutics. Moreover, public-private initiatives are further expected to fuel the growth of the market.

According to the WHO, in 2020, nearly 491.5 million people were suffering from genital herpes caused by the herpes simplex virus 2, and several billion people have herpes simplex virus 1 infection. Although the infection is typically asymptomatic, those who have it are capable of easily transmitting the virus to another person through contact. Furthermore, nearly 80 percent of the global population is a carrier of herpes. This is creating an opportunity for the growth of herpes infection treatment drugs.

Research initiatives and increasing collaborations between research organizations are facilitating the development of novel treatment alternatives against viruses, which is anticipated to boost market growth. In January 2020, a research collaboration between scientists from the EPFL in Lausanne, Switzerland, the University of Geneva (UNIGE), and the University of Manchester led to the development of novel antiviral materials, virucides, made from sugar that show promise for the treatment of herpes simplex (cold sore virus). The development of virucides from sugar has facilitated the arrival of an innovative antiviral drug, which aids treatment without being toxic to humans.

Key players operating in the market are focusing on developing novel and innovative products to meet the increasing demand for providing effective therapeutics. With the increasing demand for effective therapeutics, companies are engaged in developing novel and innovative medicines against infection. For instance, in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective Cures AG, which is a German pharmaceutical company, was commenced, post receiving encouraging Phase II interim results from the Phase II/III trial. This leading compound is developed to treat immunocompromised patients with mucocutaneous HSV infections that are acyclovir-resistant. It was granted Breakthrough Therapy Designation by the U.S. FDA in June 2020. The regulatory support for innovative therapies is projected to improve the number of new drugs entering the market, facilitating enhanced treatment rates, and thereby accelerating market growth.

Herpes Simplex Virus Treatment Market Report Highlights:

• By treatment, the HSV-1 segment held the largest share in 2023 owing to the high prevalence of infection
• By drug, the acyclovir segment is expected to grow at the fastest rate during the forecast period due to the effectiveness and availability of acyclovir as an oral and topical formulation
• By vaccine, the simplirix segment is expected to grow at the fastest rate during the forecast period as it is the only vaccine available showing promising results as a vaccine candidate
• North America dominated the global market in 2023 owing to the increasing awareness regarding STDs and the rise in healthcare expenditure

Table of Contents

Chapter 1 Herpes Simplex Virus Treatment Market: Methodology and Scope

• 1.1 Research Methodology
• 1.2 Research Assumptions
  • 1.2.1 Estimates and Forecasts timeline
• 1.3 Information Procurement
  • 1.3.1 Purchased database
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity flow analysis
    • 1.6.1.1 Approach 1: Commodity flow approach
  • 1.6.2 Volume price analysis (model 2)
    • 1.6.2.1 Approach 2: Volume price analysis
    • 1.6.2.2 Revenue modeling
• 1.7 List of Secondary Sources
• 1.8 List of Primary Sources

Chapter 2 Herpes Simplex Virus Treatment Market: Executive Summary

• 2.1 Market Summary

Chapter 3 Herpes Simplex Virus Treatment Market: Industry Outlook

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Market Dynamics
  • 3.3.1 Market Driver Analysis
    • 3.3.1.1 Growing prevalence of herpes infection
    • 3.3.1.2 Development of novel treatment options
    • 3.3.1.3 Increasing government funding
    • 3.3.1.3 Technological advancements
  • 3.3.2 Market Restraint Analysis
    • 3.3.2.1 Unavailability of vaccine
• 3.4 Porter's Five Forces Analysis
• 3.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
• 3.6 Regulatory Framework
• 3.7 User Perspective Analysis

Chapter 4 Herpes Simplex Virus Treatment Market: Competitive Landscape

• 4.1 Recent developments & impact analysis, by key market participants
  • 4.1.1 Ansoff Matrix
• 4.2 Major deals & strategic alliances analysis
  • 4.2.1 Joint Ventures
  • 4.2.2 Licensing and Partnerships
  • 4.2.3 Technological Collaborations
• 4.3 Company/Competition Categorization
• 4.4 Vendor Landscape
  • 4.4.1 List Of Key Distributors and Channel Partners
  • 4.4.2 Key Customers
• 4.5 Public Companies
  • 4.5.1 Company Market Position Analysis
• 4.6 Private Companies
  • 4.6.1 List Of Key Emerging Companies
  • 4.6.2 Regional Network Map

Chapter 5 Herpes Simplex Virus Treatment Market: Type Business Analysis

• 5.1 Definition and Scope
• 5.2 Type Market Share Analysis, 2023 & 2030
• 5.3 Global Herpes Simplex Virus Treatment Market, By Type, 2018 To 2030
• 5.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
  • 5.4.1 Herpes Simplex Virus-1 (HSV-1)
    • 5.4.1.1 Herpes Simplex Virus-1 (HSV-1) Market 2018 - 2030 (USD Million)
  • 5.4.2 Herpes Simplex Virus-2 (HSV-2)
    • 5.4.2.1 Herpes Simplex Virus-2 (HSV-2) Market, 2018 - 2030 (USD Million)

Chapter 6 Herpes Simplex Virus Treatment Market: Drug Business Analysis

• 6.1 Definition and Scope
• 6.2 Drug Market Share Analysis, 2023 & 2030
• 6.3 Global Herpes Simplex Virus Treatment Market, By Drug, 2018 To 2030
• 6.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
  • 6.4.1 Acyclovir
    • 6.4.1.1 Acyclovir Market 2018 - 2030 (USD Million)
  • 6.4.2 Valacyclovir
    • 6.4.2.1 Valacyclovir Market, 2018 - 2030 (USD Million)
  • 6.4.3 Famciclovir
    • 6.4.3.1 Famciclovir Market, 2018 - 2030 (USD Million)
  • 6.4.4 Other Drugs
    • 6.4.4.1 Other Drugs Market, 2018 - 2030 (USD Million)

Chapter 7 Herpes Simplex Virus Treatment Market: Vaccine Business Analysis

• 7.1 Definition and Scope
• 7.2 Vaccine Market Share Analysis, 2023 & 2030
• 7.3 Global Herpes Simplex Virus Treatment Market, By Vaccine, 2018 To 2030
• 7.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
  • 7.4.1 Simplirix
    • 7.4.1.1 Simplirix Market 2018 - 2030 (USD Million)
  • 7.4.2 Others
    • 7.4.2.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Herpes Simplex Virus Treatment Market: Route of Administration Business Analysis

• 8.1 Definition and Scope
• 8.2 Route of Administration Market Share Analysis, 2023 & 2030
• 8.3 Global Herpes Simplex Virus Treatment Market, By Route of Administration, 2018 To 2030
• 8.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
  • 8.4.1 Oral
    • 8.4.1.1 Oral Market 2018 - 2030 (USD Million)
  • 8.4.2 Injectable
    • 8.4.2.1 Injectable Market, 2018 - 2030 (USD Million)
  • 8.4.3 Topical
    • 8.4.3.1 Topical Market, 2018 - 2030 (USD Million)

Chapter 9 Herpes Simplex Virus Treatment Market: End-use Business Analysis

• 9.1 Definition and Scope
• 9.2 End-use Market Share Analysis, 2023 & 2030
• 9.3 Global Herpes Simplex Virus Treatment Market, By End-use, 2018 To 2030
• 9.4 Market Size & Forecasts and Trends Analysis, 2018 to 2030
  • 9.4.1 Hospital Pharmacy
    • 9.4.1.1 Hospital Pharmacy Market 2018 - 2030 (USD Million)
  • 9.4.2 Retail Pharmacy
    • 9.4.2.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 9.4.3 Online Pharmacy
    • 9.4.3.1 Online Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 10 Herpes Simplex Virus Treatment Market: Regional Business Analysis

• 10.1 Definition & Scope
• 10.2 Regional Market Share Analysis, 2023 & 2030
• 10.3 Regional Market Dashboard
• 10.4 Regional Market Snapshot
• 10.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 10.5.1 North America
  • 10.5.2 Europe
  • 10.5.3 Asia Pacific
  • 10.5.4 Latin America
  • 10.5.5 MEA
• 10.6 Market Size, & Forecasts, Trends Analysis, 2023 to 2030
• 10.7 North America
  • 10.7.1 North America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.7.2 U.S.
    • 10.7.2.1 U.S. Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.7.3 Canada
    • 10.7.3.1 Canada Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
• 10.8 Europe
  • 10.8.1 Europe Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.2 UK
    • 10.8.2.1 UK Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.3 Germany
    • 10.8.3.1 Germany Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.4 France
    • 10.8.4.1 France Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.5 Italy
    • 10.8.5.1 Italy Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.6 Spain
    • 10.8.6.1 Spain Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.7 Denmark
    • 10.8.7.1 Denmark Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.8 Sweden
    • 10.8.8.1 Sweden Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.8.9 Norway
    • 10.8.9.1 Norway Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
• 10.9 Asia Pacific
  • 10.9.1 Asia-Pacific Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.9.2 Japan
    • 10.9.2.1 Japan Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.9.3 China
    • 10.9.3.1 China Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.9.4 India
    • 10.9.4.1 India Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.9.5 Australia
    • 10.9.5.1 Australia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.9.6 South Korea
    • 10.9.6.1 South Korea Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.9.7 Thailand
    • 10.9.7.1 Thailand Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
• 10.10 Latin America
  • 10.10.1 Latin America Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.10.2 Brazil
    • 10.10.2.1 Brazil Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.10.3 Mexico
    • 10.10.3.1 Mexico Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.10.4 Argentina
    • 10.10.4.1 Argentina Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
• 10.11 MEA
  • 10.11.1 MEA Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.11.2 South Africa
    • 10.11.2.1 South Africa Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.11.3 Saudi Arabia
    • 10.11.3.1 Saudi Arabia Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.11.4 UAE
    • 10.11.4.1 UAE Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)
  • 10.11.5 Kuwait
    • 10.11.5.1 Kuwait Herpes Simplex Virus Treatment Market, 2018 - 2030 (USD Million)

Chapter 11 Herpes Simplex Virus Treatment Market: Company Profiling

• 11.1 Company Profiles
  • 11.1.1. GSK plc
    • 11.1.1.1 Company Overview
    • 11.1.1.2 Financial Performance
    • 11.1.1.3 Product Benchmarking
    • 11.1.1.4 Strategic Initiatives
  • 11.1.2. Carlsbad Tech
    • 11.1.2.1 Company Overview
    • 11.1.2.2 Financial Performance
    • 11.1.2.3 Product Benchmarking
    • 11.1.2.4 Strategic Initiatives
  • 11.1.3. Emcure Pharmaceuticals Ltd.,
    • 11.1.3.1 Company Overview
    • 11.1.3.2 Financial Performance
    • 11.1.3.3 Product Benchmarking
    • 11.1.3.4 Strategic Initiatives
  • 11.1.4. Sanofi
    • 11.1.4.1 Company Overview
    • 11.1.4.2 Financial Performance
    • 11.1.4.3 Product Benchmarking
    • 11.1.4.4 Strategic Initiatives
  • 11.1.5. Glenmark Pharmaceuticals Inc.
    • 11.1.5.1 Company Overview
    • 11.1.5.2 Financial Performance
    • 11.1.5.3 Product Benchmarking
    • 11.1.5.4 Strategic Initiatives
  • 11.1.6. Fresenius Kabi AG
    • 11.1.6.1 Company Overview
    • 11.1.6.2 Financial Performance
    • 11.1.6.3 Product Benchmarking
    • 11.1.6.4 Strategic Initiatives
  • 11.1.7. Apotex Inc.
    • 11.1.7.1 Company Overview
    • 11.1.7.2 Financial Performance
    • 11.1.7.3 Product Benchmarking
    • 11.1.7.4 Strategic Initiatives
  • 11.1.8. Viatris Inc. (Mylan)
    • 11.1.8.1 Company Overview
    • 11.1.8.2 Financial Performance
    • 11.1.8.3 Product Benchmarking
    • 11.1.8.4 Strategic Initiatives
  • 11.1.9 Teva Pharmaceuticals Industries Ltd.
    • 11.1.11.1 Company Overview
    • 11.1.9.2 Financial Performance
    • 11.1.9.3 Product Benchmarking
    • 11.1.9.4 Strategic Initiatives